Immuno-Biological Laboratories Co (TSE:4570) Scaled Net Operating Assets : 0.50 (As of Sep. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Immuno-Biological Laboratories Co Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Immuno-Biological Laboratories Co's operating assets for the quarter that ended in Sep. 2024 was 円914.8 Mil. Immuno-Biological Laboratories Co's operating liabilities for the quarter that ended in Sep. 2024 was 円111.6 Mil. Immuno-Biological Laboratories Co's Total Assets for the quarter that ended in Mar. 2024 was 円1,618.6 Mil. Therefore, Immuno-Biological Laboratories Co's scaled net operating assets (SNOA) for the quarter that ended in Sep. 2024 was 0.50.

Immuno-Biological Laboratories Co Scaled Net Operating Assets Historical Data

The historical data trend for Immuno-Biological Laboratories Co's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Immuno-Biological Laboratories Co Scaled Net Operating Assets Chart

Immuno-Biological Laboratories Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.41

0.47

0.60

0.41

0.54

Immuno-Biological Laboratories Co Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Sep24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.50	0.51	0.49	0.54	0.50

Competitive Comparison of Immuno-Biological Laboratories Co's Scaled Net Operating Assets

For the Biotechnology subindustry, Immuno-Biological Laboratories Co's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Immuno-Biological Laboratories Co's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immuno-Biological Laboratories Co's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Immuno-Biological Laboratories Co's Scaled Net Operating Assets falls into.

Immuno-Biological Laboratories Co Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Immuno-Biological Laboratories Co's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Mar. 2024 )
=	(Operating Assets (A: Mar. 2024 )	-	Operating Liabilities (A: Mar. 2024 ))	/	Total Assets (A: Mar. 2023 )
=	(884.446	-	117.289)	/	1434.337
=	0.53

where

	Operating Assets		(A: Mar. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	1618.582	-	734.136
=	884.446

	Operating Liabilities		(A: Mar. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	353.271	-	84.561	-	151.421
=	117.289

Immuno-Biological Laboratories Co's Scaled Net Operating Assets (SNOA) for the quarter that ended in Sep. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Sep. 2024 )
=	(Operating Assets (Q: Sep. 2024 )	-	Operating Liabilities (Q: Sep. 2024 ))	/	Total Assets (Q: Mar. 2024 )
=	(914.767	-	111.648)	/	1618.582
=	0.50

where

	Operating Assets		(Q: Sep. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	1645.596	-	730.829
=	914.767

	Operating Liabilities		(Q: Sep. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	308.773	-	31.997	-	165.128
=	111.648

Immuno-Biological Laboratories Co Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Immuno-Biological Laboratories Co's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Immuno-Biological Laboratories Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Immuno-Biological Laboratories Co Ltd (TSE:4570) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

1091-1 Naka Aza-Higashida, Gunma, Fujioka, JPN, 375-0005

Website

http://www.ibl-japan.co.jp

Immuno-Biological Laboratories Co Ltd focuses on research and development. It researches, develops, manufacture and supplies various immunological research reagents, and customized services. It is engaged in research and development of materials used in diagnostic products and valuable seeds and technology for protein production using transgenic silkworm cocoons, which make it possible to create valuable proteins as well as antibodies. It works on clinical reagents for cancer research. Its research scientists are producing inflammatory cytokines, growth factors & antibodies for use against these cancers.

Immuno-Biological Laboratories Co Headlines

No Headlines